IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay
Anti-Neurofascin155 antibody was measured in CIDP patients by multiple methods. The diagnostic utility of human NF155-based ELISA for screening is validated. Western blot and CBA are useful for confirmation of positive results in ELISA. Development of the optimal treatment will require gathering of more information.